血栓
纤溶
血管性血友病因子
血小板
溶栓
纤维蛋白
组织纤溶酶原激活剂
医学
细胞外
纤溶酶原激活剂
心脏病学
内科学
化学
免疫学
生物化学
心肌梗塞
作者
Jean‐Philippe Désilles,Lucas Di Meglio,François Delvoye,Benjamin Maïer,Michel Piotin,Benoît Ho‐Tin‐Noé,Mikaël Mazighi
标识
DOI:10.3389/fneur.2022.870331
摘要
During the last decade, significant progress has been made in understanding thrombus composition and organization in the setting of acute ischemic stroke (AIS). In particular, thrombus organization is now described as highly heterogeneous but with 2 preserved characteristics: the presence of (1) two distinct main types of areas in the core-red blood cell (RBC)-rich and platelet-rich areas in variable proportions in each thrombus-and (2) an external shell surrounding the core composed exclusively of platelet-rich areas. In contrast to RBC-rich areas, platelet-rich areas are highly complex and are mainly responsible for the thrombolysis resistance of these thrombi for the following reasons: the presence of platelet-derived fibrinolysis inhibitors in large amounts, modifications of the fibrin network structure resistant to the tissue plasminogen activator (tPA)-induced fibrinolysis, and the presence of non-fibrin extracellular components, such as von Willebrand factor (vWF) multimers and neutrophil extracellular traps. From these studies, new therapeutic avenues are in development to increase the fibrinolytic efficacy of intravenous (IV) tPA-based therapy or to target non-fibrin thrombus components, such as platelet aggregates, vWF multimers, or the extracellular DNA network.
科研通智能强力驱动
Strongly Powered by AbleSci AI